Order Article Reprints

Quagliariello V, Di Mauro A, Ferrara G, Bruzzese F, Palma G, Luciano A, Canale ML, Bisceglia I, Iovine M, Cadeddu Dessalvi C, et al. Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants. 2025; 14(5):612. https://doi.org/10.3390/antiox14050612

Quagliariello, Vincenzo, Annabella Di Mauro, Gerardo Ferrara, Francesca Bruzzese, Giuseppe Palma, Antonio Luciano, Maria Laura Canale, Irma Bisceglia, Martina Iovine, Christian Cadeddu Dessalvi, and et al. 2025. "Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity" Antioxidants 14, no. 5: 612. https://doi.org/10.3390/antiox14050612

Quagliariello, V., Di Mauro, A., Ferrara, G., Bruzzese, F., Palma, G., Luciano, A., Canale, M. L., Bisceglia, I., Iovine, M., Cadeddu Dessalvi, C., Maurea, C., Barbato, M., Inno, A., Berretta, M., Paccone, A., Mauriello, A., Fonderico, C., Maratea, A. C., & Maurea, N. (2025). Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity. Antioxidants, 14(5), 612. https://doi.org/10.3390/antiox14050612